Home >News & Events>Press Release

Press Release

Institut Pasteur Korea to Showcase Drug Discovery at Gyeonggi Science Festival
September 04, 2017

- Encouraging stronger curiosity in research science and innovation in the next generation of scientists

Pangyo, Gyeonggi, 4 Sept, 2017 | Institut Pasteur Korea (IPK, CEO: Dr. Wang-Shick Ryu) will participate in the Gyeonggi Science Festival at Bucheon on 9 Sept and at Dongducheon on 23 Sept. IPK’s interactive program “Drug Discover? It's not difficult.” will inspire both young and old in drug discovery and innova-tion. Every year IPK participates in local and international scientific festivals to highlight the contributions and impact drug discovery advancements have on society and the economy.

At this year’s Gyeonggi Science Festival, visitors will be presented with a range of multi-sensory activities, easy to understand diagrams and pictures that explain the drug discovery process. Also, they will have a chance to perform a hands-on chromatography experiment using chocolate, to demonstrate scientific theory and understand the importance of science in their daily lives.

Education, teaching and community outreach are important tent poles of Louis Pasteur’s legacy. Since 2009, IPK has been an active participant in the ‘Gyeonggi Mentor Project’ and piloted a number of edu-cational programs for children and continuing education programs for young scientists. Approximately 1,600 students have benefited from IPK’s educational programs that nurture the development of future global health scientists and leaders and expands scientific culture in Korea.


For more information on our various educational programs, please visit us on http://www.ip-korea.org or contact us at t: 031-8018-8041, e: publicaffairs@ip-korea.org.

#  #  #  #  #  #

About Institut Pasteur Korea
Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and an economic growth engine that contributes to Korea's scientific intellectual and technical resources. IPK has four core missions of public interest; 1) Research, combining front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases, 2) Education, offering a wide range of programming to nurture the development of the next generation of scientists and health professionals, 3) Public Health, working in collaboration with national and international health authorities, and 4) Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
IPK is a member of the Institut Pasteur International Network (Network). As a hub institution, IPK plays a key role in the Network, serving as a bridge between Korea and global bio-pharma science, expanding Korea's R&D base collaborative research projects with global alliances
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science, ICT and Future Planning (MSIP). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).